MedTrace Logo

Shock Wave vs. On-demand Tadalafil for Erectile Dysfunction

NCT05199727 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-01-20

No results posted yet for this study

Summary

The objective of this study is to evaluate the effectiveness and safety of focused Li-ESWT on 25 participants complaining of ED compared to 25 participants complaining of ED on medical treatment on a prospective clinical trial for 12 weeks.

Conditions

Interventions

DEVICE

LI-ESWT

Low intenisty shockwave therapy newly used for treatment of erectile dysfunction by applying 6 sessions on 3 weeks (2 sessions /week)

DRUG

Tadalafil 20Mg Oral Tablet

Patients on this arm will allocate on on-demand tadalafil 20 mg for treatment of ED

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Principal Investigators

  • fouad zanaty, professor · Menoufia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2022-03-31
Completion
2022-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05199727 on ClinicalTrials.gov